Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Johnson

Showing results (701-710 of 760) with videos related to

Pageof 76
Sort By:
Cancers|November 13, 2013
Glioma surgical aspirate: a viable source of tumor tissue for experimental researchBryan W Day, Brett W Stringer, John Wilson, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 26, 2021
FACE-Q craniofacial module: Part 2 Psychometric properties of newly developed scales for children and young adults with facial conditionsAnne F Klassen, Charlene Rae, Wong Riff, et al.
Science Translational Medicine|February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipaseRachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
American Journal of Medical Genetics. Part A|February 14, 2019
ERF-related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndromeGraeme E Glass, Justine O'Hara, Natalie Canham, et al.
Clinical Lung Cancer|February 11, 2025
CNS Outcomes of Osimertinib Plus Chemotherapy in Patients With EGFR Mutation Positive Lung Cancer Beyond Osimertinib ProgressionWesley K Y Wong, Kevin K S Mok, Giselle P C Tsui, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinibAllen C C Chen, Florence S T Mok, Wesley K Y Wong, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 28, 2024
Factors that impact second attempt success for neonatal intubation following first attempt failure: a report from the National Emergency Airway Registry for NeonatesMitchell David Johnson, David Gerald Tingay, Elizabeth J Perkins, et al.
The Psychiatric Clinics of North America|May 9, 2024
Improving Exposure Therapy: Rationale and Design of an International ConsortiumJasper A J Smits, Jonathan S Abramowitz, Joanna J Arch, et al.
Advances in Radiation Oncology|June 16, 2018
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704William F Regine, Kathryn Winter, Ross A Abrams, et al.
Faraday Discussions|November 20, 2014
Functionalisation, separation and solvation: general discussionNazario Martín, Philip Davies, Chris Ewels, et al.
Pageof 76

Showing results (701-710 of 760) with videos related to

Sort By:
Pageof 76
Cancers|November 13, 2013
Glioma surgical aspirate: a viable source of tumor tissue for experimental researchBryan W Day, Brett W Stringer, John Wilson, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 26, 2021
FACE-Q craniofacial module: Part 2 Psychometric properties of newly developed scales for children and young adults with facial conditionsAnne F Klassen, Charlene Rae, Wong Riff, et al.
Science Translational Medicine|February 12, 2016
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipaseRachael Jarrett, Mariolina Salio, Antonia Lloyd-Lavery, et al.
American Journal of Medical Genetics. Part A|February 14, 2019
ERF-related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndromeGraeme E Glass, Justine O'Hara, Natalie Canham, et al.
Clinical Lung Cancer|February 11, 2025
CNS Outcomes of Osimertinib Plus Chemotherapy in Patients With EGFR Mutation Positive Lung Cancer Beyond Osimertinib ProgressionWesley K Y Wong, Kevin K S Mok, Giselle P C Tsui, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinibAllen C C Chen, Florence S T Mok, Wesley K Y Wong, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 28, 2024
Factors that impact second attempt success for neonatal intubation following first attempt failure: a report from the National Emergency Airway Registry for NeonatesMitchell David Johnson, David Gerald Tingay, Elizabeth J Perkins, et al.
The Psychiatric Clinics of North America|May 9, 2024
Improving Exposure Therapy: Rationale and Design of an International ConsortiumJasper A J Smits, Jonathan S Abramowitz, Joanna J Arch, et al.
Advances in Radiation Oncology|June 16, 2018
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704William F Regine, Kathryn Winter, Ross A Abrams, et al.
Faraday Discussions|November 20, 2014
Functionalisation, separation and solvation: general discussionNazario Martín, Philip Davies, Chris Ewels, et al.
Pageof 76